Literature DB >> 21326345

Bethanechol and N-acetylcysteine mimic feeding signals and reverse insulin resistance in fasted and sucrose-induced diabetic rats.

W Wayne Lautt1, Joshua Schafer, M Paula Macedo, Dallas J Legare.   

Abstract

Meal-induced insulin sensitization (MIS) is explained by the HISS (hepatic insulin sensitizing substance) hypothesis. In the presence of two "feeding signals," a pulse of insulin results in the release of HISS from the liver. HISS acts selectively on skeletal muscle and doubles the response to insulin. HISS is not released in the fasted state or in the sucrose-supplemented diabetes model. We tested the hypothesis that provision of both feeding signals allows insulin to cause HISS release in both the normal fasted and the diabetic model. The dynamic response to insulin (50 mU/kg over 5 min) was quantified using the rapid insulin sensitivity test (RIST). Gastric injection of a liquid test meal or i.v. administration of N-acetylcysteine in 24 h fasted rats raised hepatic glutathione to a similar degree (by 46%-47%). Hepatic denervation in fed rats eliminated the parasympathetic signal and eliminated MIS, and bethanechol completely restored MIS. Both compounds administered together allowed insulin to stimulate HISS release in 24 h fasted rats and in a diabetic model (9-week, 35% liquid sucrose supplement). Neither was effective alone. Both "feeding signals" are necessary and sufficient for insulin to stimulate HISS release.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21326345     DOI: 10.1139/y11-001

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  4 in total

1.  Meal-induced insulin sensitization is preserved after acute olanzapine administration in female Sprague-Dawley rats.

Authors:  Diána Kovács; Csaba Hegedűs; Rita Kiss; Réka Sári; József Németh; Zoltán Szilvássy; Barna Peitl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-03       Impact factor: 3.000

Review 2.  Risk of postprandial insulin resistance: the liver/vagus rapport.

Authors:  Maria Paula Macedo; Inês S Lima; Joana M Gaspar; Ricardo A Afonso; Rita S Patarrão; Young-Bum Kim; Rogério T Ribeiro
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

3.  Fatty Liver and Fatty Heart-Where do They Stand in the AMIS Syndrome?

Authors:  W Wayne Lautt; Zhi Ming; Dallas J Legare; Kawshik K Chowdhury; Grant M Hatch; Hui Helen Wang
Journal:  Healthcare (Basel)       Date:  2015-08-11

Review 4.  Obesity as an Early Symptom of the AMIS Syndrome.

Authors:  W Wayne Lautt; Hui Helen Wang
Journal:  J Clin Med       Date:  2014-10-28       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.